Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico

Autores:
Florez Romero , Andres
Rojas , William
Reverend L. , Carlos
Torres , Lilian
Quintero , Gloria
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2898
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2898
https://doi.org/10.31260/RepertMedCir.01217273.888
Palabra clave:
proteína moduladora de la actividad del receptor de aril hidrocarburos
neoplasias hipofisarias
enfermedades de la hipófisis
acromegalia
gigantismo
aryl hydrocarbon receptor interacting protein
pituitary neoplasia
pituitary diseases
acromegaly
gigantism
Rights
openAccess
License
Revista Repertorio de Medicina y Cirugía - 2021
id FUCS2_debeacde9bd67dfd337d837e48a11a5a
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2898
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
dc.title.translated.eng.fl_str_mv Aryl hydrocarbon receptor interacting protein (AIP): genetics, biochemistry and clinical impact
title Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
spellingShingle Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
proteína moduladora de la actividad del receptor de aril hidrocarburos
neoplasias hipofisarias
enfermedades de la hipófisis
acromegalia
gigantismo
aryl hydrocarbon receptor interacting protein
pituitary neoplasia
pituitary diseases
acromegaly
gigantism
title_short Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
title_full Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
title_fullStr Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
title_full_unstemmed Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
title_sort Proteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínico
dc.creator.fl_str_mv Florez Romero , Andres
Rojas , William
Reverend L. , Carlos
Torres , Lilian
Quintero , Gloria
dc.contributor.author.spa.fl_str_mv Florez Romero , Andres
Rojas , William
Reverend L. , Carlos
Torres , Lilian
Quintero , Gloria
dc.subject.spa.fl_str_mv proteína moduladora de la actividad del receptor de aril hidrocarburos
neoplasias hipofisarias
enfermedades de la hipófisis
acromegalia
gigantismo
topic proteína moduladora de la actividad del receptor de aril hidrocarburos
neoplasias hipofisarias
enfermedades de la hipófisis
acromegalia
gigantismo
aryl hydrocarbon receptor interacting protein
pituitary neoplasia
pituitary diseases
acromegaly
gigantism
dc.subject.eng.fl_str_mv aryl hydrocarbon receptor interacting protein
pituitary neoplasia
pituitary diseases
acromegaly
gigantism
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-04-07 14:55:28
2022-06-29T19:37:38Z
dc.date.issued.none.fl_str_mv 2021-04-07
dc.date.available.none.fl_str_mv 2021-04-07 14:55:28
2022-06-29T19:37:38Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_dcae04bc
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.01217273.888
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2898
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.01217273.888
identifier_str_mv 10.31260/RepertMedCir.01217273.888
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2898
https://doi.org/10.31260/RepertMedCir.01217273.888
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006;312(5777):1228-30. doi: 10.1126/science.1126100
Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain- Rea ML, Barlier A, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab. 2010;95(11):E373-83. doi: 10.1210/jc.2009-2556
Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013;34(2):239-77. doi: 10.1210/er.2012-1013
AIP Gene (Protein Coding). Aryl Hydrocarbon Receptor Interacting Protein [Internet]. The GeneCards human gene database; [citado 2019 enero]; Recuperado de: https://www.genecards.org/cgi-bin/ carddisp.pl?gene=AIP.
Exon Structure for AIP [Internet]. GeneLoc Genome Locator; [citado 2019 enero]; Recuperado de: https://genecards.weizmann. ac.il/geneloc-bin/exon_struct.pl?disp_name=AIP&chr_nr=11)..
Gadelha MR, Trivellin G, Hernández Ramírez LC, Korbonits M. Genetics of pituitary adenomas. Front Horm Res. 2013;41:111-40. doi: 10.1159/000345673
Hernández-Ramírez LC, Martucci F, Morgan RM, Trivellin G, Tilley D, Ramos-Guajardo N, et al. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations. J Clin Endocrinol Metab. 2016;101(8):3144-54. doi: 10.1210/jc.2016- 1307
Lecoq AL, Viengchareun S, Hage M, Bouligand J, Young J, Boutron A, et al. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. Endocr Relat Cancer. 2016;23(5):433-43. doi: 10.1530/ERC-16-0041
Tuominen I, Heliövaara E, Raitila A, Rautiainen MR, Mehine M, Katainen R, et al. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling. Oncogene. 2015;34(9):1174-84. doi: 10.1038/onc.2014.50
Hernández-Ramírez LC, Trivellin G, Stratakis CA. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants. Horm Metab Res. 2017;49(4):286-95. doi: 10.1055/s-0043-104700
Trivellin G, Korbonits M. AIP and its interacting partners. J Endocrinol. 2011;210(2):137-55. doi: 10.1530/JOE-11-0054
Lloyd C, Grossman A. The AIP (aryl hydrocarbon receptor- interacting protein) gene and its relation to the pathogenesis of pituitary adenomas. Endocrine. 2014;46(3):387-96. doi: 10.1007/ s12020-013-0125-6
Fajardo-Montañana C, Daly AF, Riesgo-Suárez P, Gómez-Vela J, Tichomirowa MA, Camara-Gómez R, et al. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]. Endocrinol Nutr. 2009;56(7):369-77. doi: 10.1016/S1575-0922(09)72456-8
Cannavo S, Trimarchi F, Ferraù F. Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Mol Cell Endocrinol. 2017;457:81-8. doi: 10.1016/j. mce.2016.12.019
Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab. 2010;21(7):419-27. doi: 10.1016/j.tem.2010.02.007
Formosa R, Xuereb-Anastasi A, Vassallo J. Aip regulates cAMP signalling and GH secretion in GH3 cells. Endocr Relat Cancer. 2013;20(4):495-505. doi: 10.1530/ERC-13-0043
Raitila A, Lehtonen HJ, Arola J, Heliövaara E, Ahlsten M, Georgitsi M, et al. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am J Pathol. 2010;177(4):1969-76. doi: 10.2353/ajpath.2010.100138
Goldfarb SB, Kashlan OB, Watkins JN, Suaud L, Yan W, Kleyman TR, et al. Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels. Proc Natl Acad Sci U S A. 2006;103(15):5817-22. doi: 10.1073/pnas.0507903103
Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 2010;31(8):950-60. doi: 10.1002/humu.21292
Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab. 2007;92(5):1952-5. doi: 10.1210/jc.2006-2702
Formosa R, Vassallo J. Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function. Horm Cancer. 2017;8(3):174-84. doi: 10.1007/s12672-017-0288-3
Rostomyan L, Potorac I, Beckers P, Daly AF, Beckers A. AIP mutations and gigantism. Ann Endocrinol (Paris). 2017;78(2):123- 30. doi: 10.1016/j.ando.2017.04.012
Korbonits M, Storr H, Kumar AV. Familial pituitary adenomas - who should be tested for AIP mutations? Clin Endocrinol (Oxf). 2012;77(3):351-6. doi: 10.1111/j.1365-2265.2012.04445.x
Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol (Oxf). 2007;66(4):499-502. doi: 10.1111/j.1365-2265.2007.02758.x
Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea ML, Ronchi C, Yaneva M, et al. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol. 2011;165(4):509-15. doi: 10.1530/EJE-11-0304
Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab. 2007;92(5):1891- 6. doi: 10.1210/jc.2006-2513
Gadelha MR, Kasuki L, Korbonits M. The genetic background of acromegaly. Pituitary. 2017;20(1):10-21. doi: 10.1007/s11102-017- 0789-7
Kasuki Jomori de Pinho L, Vieira Neto L, Armondi Wildemberg LE, Gasparetto EL, Marcondes J, de Almeida Nunes B, et al. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. Neuroendocrinology. 2011;94(1):39-48. doi: 10.1159/000322787
Oriola J, Lucas T, Halperin I, Mora M, Perales MJ, Alvarez-Escolá C, et al. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues. Eur J Endocrinol. 2013;168(1):9-13. doi: 10.1530/EJE-12-0457
Ibáñez-Costa A, Korbonits M. AIP and the somatostatin system in pituitary tumours. J Endocrinol. 2017;235(3):R101-R16. doi: 10.1530/JOE-17-0254
Chahal HS, Trivellin G, Leontiou CA, Alband N, Fowkes RC, Tahir A, et al. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. J Clin Endocrinol Metab. 2012;97(8):E1411-20. doi: 10.1210/jc.2012-1111
Tong A, Jiang J, Wang F, Li C, Zhang Y, Wu X. Pure androgen- producing adrenal tumor: clinical features and pathogenesis. Endocr Pract. 2017;23(4):399-407. doi: 10.4158/EP161580.OR
Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, et al. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br J Cancer. 2007;96(2):352-6. doi: 10.1038/sj.bjc.6603573
Raitila A, Georgitsi M, Karhu A, Tuppurainen K, Mäkinen MJ, Birkenkamp-Demtröder K, et al. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocr Relat Cancer. 2007;14(3):901-6. doi: 10.1677/ERC-07-0025
Raitila A, Georgitsi M, Bonora E, Vargiolu M, Tuppurainen K, Mäkinen MJ, et al. Aryl hydrocarbon receptor interacting protein mutations seem not to associate with familial non-medullary thyroid cancer. J Endocrinol Invest. 2009;32(5):426-9. doi: 10.1007/BF03346480
Magnusson L, Hansen N, Saba KH, Nilsson J, Fioretos T, Rissler P, et al. Loss of the tumour suppressor gene AIP mediates the browning of human brown fat tumours. J Pathol. 2017;243(2):160- 4. doi: 10.1002/path.4945
Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, et al. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. J Clin Endocrinol Metab. 2013;98(7):2800-10. doi: 10.1210/jc.2012-4029
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1188
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1434
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/2005
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1476
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1454
dc.relation.citationedition.spa.fl_str_mv Núm. 1 , Año 2021 : Enero - Abril
dc.relation.citationendpage.none.fl_str_mv 21
dc.relation.citationissue.spa.fl_str_mv 1
dc.relation.citationstartpage.none.fl_str_mv 13
dc.relation.citationvolume.spa.fl_str_mv 30
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía - 2021
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Revista Repertorio de Medicina y Cirugía - 2021
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
text/html
application/epub+zip
text/xml
audio/mpeg
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/888
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/db983b01-1de4-4958-8f41-e4a3467269d9/download
bitstream.checksum.fl_str_mv dee42585734170e6e362b1a67baad71b
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355564312920064
spelling Florez Romero , Andresb33be62da91dc8d08978b15ee2a2e4a4300Rojas , Williamc1d10fe4923393188d8d69f64877a441Reverend L. , Carlos6770d640e54caa448ab5e031cbe129f0300Torres , Lilian9fe3ae5f0a66cf517714e8044c501ce1Quintero , Gloria2507f4a0a4e0bb5e9c2f0e4972d118a22021-04-07 14:55:282022-06-29T19:37:38Z2021-04-072021-04-07 14:55:282022-06-29T19:37:38ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludRevista Repertorio de Medicina y Cirugía - 2021info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/888proteína moduladora de la actividad del receptor de aril hidrocarburosneoplasias hipofisariasenfermedades de la hipófisisacromegaliagigantismoaryl hydrocarbon receptor interacting proteinpituitary neoplasiapituitary diseasesacromegalygigantismProteína moduladora de la actividad del receptor de aril hidrocarburos (AIP): genética, bioquímica e impacto clínicoAryl hydrocarbon receptor interacting protein (AIP): genetics, biochemistry and clinical impactapplication/pdftext/htmlapplication/epub+ziptext/xmlaudio/mpegArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.01217273.8880121-7372https://repositorio.fucsalud.edu.co/handle/001/28982462-991Xhttps://doi.org/10.31260/RepertMedCir.01217273.888spaVierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006;312(5777):1228-30. doi: 10.1126/science.1126100Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain- Rea ML, Barlier A, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab. 2010;95(11):E373-83. doi: 10.1210/jc.2009-2556Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013;34(2):239-77. doi: 10.1210/er.2012-1013AIP Gene (Protein Coding). Aryl Hydrocarbon Receptor Interacting Protein [Internet]. The GeneCards human gene database; [citado 2019 enero]; Recuperado de: https://www.genecards.org/cgi-bin/ carddisp.pl?gene=AIP.Exon Structure for AIP [Internet]. GeneLoc Genome Locator; [citado 2019 enero]; Recuperado de: https://genecards.weizmann. ac.il/geneloc-bin/exon_struct.pl?disp_name=AIP&chr_nr=11)..Gadelha MR, Trivellin G, Hernández Ramírez LC, Korbonits M. Genetics of pituitary adenomas. Front Horm Res. 2013;41:111-40. doi: 10.1159/000345673Hernández-Ramírez LC, Martucci F, Morgan RM, Trivellin G, Tilley D, Ramos-Guajardo N, et al. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations. J Clin Endocrinol Metab. 2016;101(8):3144-54. doi: 10.1210/jc.2016- 1307Lecoq AL, Viengchareun S, Hage M, Bouligand J, Young J, Boutron A, et al. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. Endocr Relat Cancer. 2016;23(5):433-43. doi: 10.1530/ERC-16-0041Tuominen I, Heliövaara E, Raitila A, Rautiainen MR, Mehine M, Katainen R, et al. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling. Oncogene. 2015;34(9):1174-84. doi: 10.1038/onc.2014.50Hernández-Ramírez LC, Trivellin G, Stratakis CA. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants. Horm Metab Res. 2017;49(4):286-95. doi: 10.1055/s-0043-104700Trivellin G, Korbonits M. AIP and its interacting partners. J Endocrinol. 2011;210(2):137-55. doi: 10.1530/JOE-11-0054Lloyd C, Grossman A. The AIP (aryl hydrocarbon receptor- interacting protein) gene and its relation to the pathogenesis of pituitary adenomas. Endocrine. 2014;46(3):387-96. doi: 10.1007/ s12020-013-0125-6Fajardo-Montañana C, Daly AF, Riesgo-Suárez P, Gómez-Vela J, Tichomirowa MA, Camara-Gómez R, et al. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]. Endocrinol Nutr. 2009;56(7):369-77. doi: 10.1016/S1575-0922(09)72456-8Cannavo S, Trimarchi F, Ferraù F. Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Mol Cell Endocrinol. 2017;457:81-8. doi: 10.1016/j. mce.2016.12.019Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab. 2010;21(7):419-27. doi: 10.1016/j.tem.2010.02.007Formosa R, Xuereb-Anastasi A, Vassallo J. Aip regulates cAMP signalling and GH secretion in GH3 cells. Endocr Relat Cancer. 2013;20(4):495-505. doi: 10.1530/ERC-13-0043Raitila A, Lehtonen HJ, Arola J, Heliövaara E, Ahlsten M, Georgitsi M, et al. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am J Pathol. 2010;177(4):1969-76. doi: 10.2353/ajpath.2010.100138Goldfarb SB, Kashlan OB, Watkins JN, Suaud L, Yan W, Kleyman TR, et al. Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels. Proc Natl Acad Sci U S A. 2006;103(15):5817-22. doi: 10.1073/pnas.0507903103Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, et al. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 2010;31(8):950-60. doi: 10.1002/humu.21292Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab. 2007;92(5):1952-5. doi: 10.1210/jc.2006-2702Formosa R, Vassallo J. Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function. Horm Cancer. 2017;8(3):174-84. doi: 10.1007/s12672-017-0288-3Rostomyan L, Potorac I, Beckers P, Daly AF, Beckers A. AIP mutations and gigantism. Ann Endocrinol (Paris). 2017;78(2):123- 30. doi: 10.1016/j.ando.2017.04.012Korbonits M, Storr H, Kumar AV. Familial pituitary adenomas - who should be tested for AIP mutations? Clin Endocrinol (Oxf). 2012;77(3):351-6. doi: 10.1111/j.1365-2265.2012.04445.xIwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol (Oxf). 2007;66(4):499-502. doi: 10.1111/j.1365-2265.2007.02758.xTichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea ML, Ronchi C, Yaneva M, et al. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol. 2011;165(4):509-15. doi: 10.1530/EJE-11-0304Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab. 2007;92(5):1891- 6. doi: 10.1210/jc.2006-2513Gadelha MR, Kasuki L, Korbonits M. The genetic background of acromegaly. Pituitary. 2017;20(1):10-21. doi: 10.1007/s11102-017- 0789-7Kasuki Jomori de Pinho L, Vieira Neto L, Armondi Wildemberg LE, Gasparetto EL, Marcondes J, de Almeida Nunes B, et al. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. Neuroendocrinology. 2011;94(1):39-48. doi: 10.1159/000322787Oriola J, Lucas T, Halperin I, Mora M, Perales MJ, Alvarez-Escolá C, et al. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues. Eur J Endocrinol. 2013;168(1):9-13. doi: 10.1530/EJE-12-0457Ibáñez-Costa A, Korbonits M. AIP and the somatostatin system in pituitary tumours. J Endocrinol. 2017;235(3):R101-R16. doi: 10.1530/JOE-17-0254Chahal HS, Trivellin G, Leontiou CA, Alband N, Fowkes RC, Tahir A, et al. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. J Clin Endocrinol Metab. 2012;97(8):E1411-20. doi: 10.1210/jc.2012-1111Tong A, Jiang J, Wang F, Li C, Zhang Y, Wu X. Pure androgen- producing adrenal tumor: clinical features and pathogenesis. Endocr Pract. 2017;23(4):399-407. doi: 10.4158/EP161580.ORGeorgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, et al. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br J Cancer. 2007;96(2):352-6. doi: 10.1038/sj.bjc.6603573Raitila A, Georgitsi M, Karhu A, Tuppurainen K, Mäkinen MJ, Birkenkamp-Demtröder K, et al. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocr Relat Cancer. 2007;14(3):901-6. doi: 10.1677/ERC-07-0025Raitila A, Georgitsi M, Bonora E, Vargiolu M, Tuppurainen K, Mäkinen MJ, et al. Aryl hydrocarbon receptor interacting protein mutations seem not to associate with familial non-medullary thyroid cancer. J Endocrinol Invest. 2009;32(5):426-9. doi: 10.1007/BF03346480Magnusson L, Hansen N, Saba KH, Nilsson J, Fioretos T, Rissler P, et al. Loss of the tumour suppressor gene AIP mediates the browning of human brown fat tumours. J Pathol. 2017;243(2):160- 4. doi: 10.1002/path.4945Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, et al. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. J Clin Endocrinol Metab. 2013;98(7):2800-10. doi: 10.1210/jc.2012-4029https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1188https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1434https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/2005https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1476https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/888/1454Núm. 1 , Año 2021 : Enero - Abril2111330Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2939https://repositorio.fucsalud.edu.co/bitstreams/db983b01-1de4-4958-8f41-e4a3467269d9/downloaddee42585734170e6e362b1a67baad71bMD51001/2898oai:repositorio.fucsalud.edu.co:001/28982024-02-02 13:10:54.891https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Repertorio de Medicina y Cirugía - 2021metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co